Certara Inc
Închisă
SectorSănătate
7.55 1.75
Rezumat
Modificarea prețului
24h
Minim
7.46
Maxim
7.5600000000000005
Venit | -380K -9.1M |
|---|---|
Vânzări | -14M 93M |
P/E Medie Sector | 100.714 56.597 |
EPS | 0.05 |
Marjă de profit | -9.803 |
Angajați | 1,515 |
EBITDA | -4.2M 12M |
Următoarele câștiguri | 5 nov. 2026 |
|---|
Capitalizare de piață | -61M 1.2B |
|---|---|
Deschiderea anterioară | 5.8 |
Închiderea anterioară | 7.55 |
Sentimentul știrilor
By Acuity
50%
50%
126 / 339 Clasament în Healthcare
Certara Inc Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
Certara Inc Așteptări
Sentiment
By Acuity
126 / 339 Clasament în Sănătate
Sentimentul știrilor
Neutral
Volatilitate
Sub medie
Volumul știrilor (RCV)
Sub medie
Date financiare
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$
Despre Certara Inc
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
